Disclosure of shareholding
Pursuant to article 26 sec 1 clause 2 WpHG, BB Biotech AG, Schaffhausen, Switzerland, herby reports that it increased its holding in own shares to more than 3% of the proportion of voting rights as of November 5, 2013 (a total of 356 639 shares / 3.01% of the proportion of voting rights).
Thereof, 0.27% of the proportion of voting rights (a total of 31 639 shares) are held through its wholly-owned subsidiary Biotech Target N.V., Curaçao.
For further information: Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht / Zürich
Tanja Chicherio, Tel. +41 44 267 67 00.
Schaffhausen, November 7, 2013
BB Biotech AG
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE
HUG#1741117